Ethchlorvynol

CHEMBL591 Phase 4 Approuvé Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
144.6 g/mol
LogP
1.5
Phase
4

This older central nervous system depressant has sedative and hypnotic properties and was historically used for short-term treatment of insomnia. It is no longer widely used due to concerns about dependence and side effects.

Masse moléculaire

144,6000 g/mol

LogP

1,50

TPSA

20,20 Ų

Règle des 5 de Lipinski

Conforme

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C#CC(O)(/C=C/Cl)CC

InChI

InChI=1S/C7H9ClO/c1-3-7(9,4-2)5-6-8/h1,5-6,9H,4H2,2H3/b6-5+

Molecular Formula

C7H9ClO

HBD / HBA

1 / 1

Liaisons Rotatives

3

Atomes Lourds

9

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

This older central nervous system depressant has sedative and hypnotic properties and was historically used for short-term treatment of insomnia. It is no longer widely used due to concerns about dependence and side effects.

Yes, Ethchlorvynol is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL591. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 5281077. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.